T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Kennametal
KMT
$2.32B
| $1.14M | ﹤0.01% |
61,094
+5,510
| +10% | +$157K |
|
1652
S&T Bancorp
STBA
$1.82B
| $1.14M | ﹤0.01% |
41,647
+2,350
| +6% | +$82K |
|
1653
Nutanix
NTNX
$18.4B
| $1.13M | ﹤0.01% |
71,541
-322,772
| -82% | -$9.07M |
|
|
DESP
1654
DELISTED
Despegar.com
DESP
| $1.13M | ﹤0.01% |
+199,200
| New | +$2.36M |
|
|
GRA
1655
DELISTED
W.R. Grace & Co.
GRA
| $1.13M | ﹤0.01% |
31,644
-948
| -3% | -$54.1K |
|
1656
Renasant Corp
RNST
$4B
| $1.12M | ﹤0.01% |
51,339
+567
| +1% | +$16.8K |
|
1657
Pediatrix Medical
MD
$2.14B
| $1.12M | ﹤0.01% |
96,168
+20,099
| +26% | +$415K |
|
|
SC
1658
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.11M | ﹤0.01% |
79,854
+11,779
| +17% | +$262K |
|
1659
Lakeland Financial Corp
LKFN
$1.56B
| $1.11M | ﹤0.01% |
30,156
+1,202
| +4% | +$52.3K |
|
1660
MGIC Investment
MTG
$6.33B
| $1.11M | ﹤0.01% |
174,431
-819,811
| -82% | -$9.91M |
|
1661
JD.com
JD
$39.6B
| $1.11M | ﹤0.01% |
27,300
+1,200
| +5% | +$47.9K |
|
1662
KBR
KBR
$4.81B
| $1.09M | ﹤0.01% |
52,878
-939,865
| -95% | -$24.3M |
|
1663
U-Haul Holding Co
UHAL
$14.4B
| $1.09M | ﹤0.01% |
37,660
+80
| +0.2% | +$2.7K |
|
|
VRE
1664
DELISTED
Veris Residential
VRE
| $1.09M | ﹤0.01% |
71,706
+500
| +0.7% | +$10.2K |
|
|
SYKE
1665
DELISTED
SYKES Enterprises Inc
SYKE
| $1.09M | ﹤0.01% |
40,273
+249
| +0.6% | +$8.03K |
|
|
APLT
1666
DELISTED
Applied Therapeutics
APLT
| $1.09M | ﹤0.01% |
+33,385
| New | +$1.35M |
|
1667
RE/MAX Holdings
RMAX
$265M
| $1.09M | ﹤0.01% |
49,657
-3,270
| -6% | -$107K |
|
1668
Simmons First National
SFNC
$3.46B
| $1.08M | ﹤0.01% |
58,907
+10,227
| +21% | +$232K |
|
1669
Atlantic Union Bankshares
AUB
$6.09B
| $1.08M | ﹤0.01% |
49,269
+7,502
| +18% | +$232K |
|
1670
Milestone Pharmaceuticals
MIST
$133M
| $1.08M | ﹤0.01% |
584,615
-701,892
| -55% | -$12.2M |
|
|
SGMO
1671
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.08M | ﹤0.01% |
168,969
+47,021
| +39% | +$349K |
|
1672
Rogers Corp
ROG
$2.46B
| $1.07M | ﹤0.01% |
11,380
+200
| +2% | +$22.7K |
|
|
DMC
1673
Del Monte Corp
DMC
$1.44B
| $1.06M | ﹤0.01% |
38,417
+781
| +2% | +$24.8K |
|
1674
Outfront Media
OUT
$5.24B
| $1.06M | ﹤0.01% |
79,983
+20,860
| +35% | +$510K |
|
1675
Ashland
ASH
$3.36B
| $1.06M | ﹤0.01% |
21,145
+2,188
| +12% | +$151K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.